Gilead Sciences Announces Topline Results From Phase 3 TROPiCS-04 Study In Metastatic Urothelial Cancer; Trodelvy Fails To Meet Primary Endpoint Of Overall Survival
Gilead Sciences Announces Topline Results From Phase 3 TROPiCS-04 Study In Metastatic Urothelial Cancer; Trodelvy Fails To Meet Primary Endpoint Of Overall Survival
吉利德科學公佈了轉移性尿路上皮癌的3期Tropics-04研究的主要結果；Trodelvy未能達到總存活率的主要終點
Gilead Sciences Announces Topline Results From Phase 3 TROPiCS-04 Study In Metastatic Urothelial Cancer; Trodelvy Fails To Meet Primary Endpoint Of Overall Survival
吉利德科學公佈了轉移性尿路上皮癌的3期Tropics-04研究的主要結果；Trodelvy未能達到總存活率的主要終點
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。